Dr. Charles Fortune, radiation oncologist at John B. Amos Cancer Center stopped by WRBL News 3 and chatted with anchor Teresa ...

Dr. Nik Patel with the Scripps Cancer Center joined CBS 8 to talk about an emerging cancer treatment that is offering new ...

Prostate cancer survivor, Neil Matthewson, joined CBS 8 to discuss his journey and what he's doing to raise awareness.

Joe Cala, 75, faces prostate cancer again despite initial successful treatment, but stays active with family support and medical care.

Excess body weight, as measured by BMI, is associated with improved overall survival (OS) in men with advanced prostate cancer, particularly those with metastatic castration-resistant disease, a ...

For the third year in a row, Cleveland Diagnostics is commemorating September’s Prostate Cancer Awareness Month with its “A PSA on PSA” campaign, which serves as a public service announcement about ...

University of Kentucky Markey Cancer Center researchers have identified a cellular pathway that fuels the progression of aggressive, drug-resistant prostate cancer. The findings of the study, ...

Please provide your email address to receive an email when new articles are posted on . Men who have depression before prostate cancer diagnosis may have significantly greater risk for death than ...

Dr. Dre would be the perfect pitchman for prostate cancer awareness efforts. The rap mogul shares an acronym for an important aspect of prostate cancer probes. Digital rectal examination (DRE) ...

Editor's note: The Larger Trend section has been updated. California-based Artera, a company that develops multimodal AI-based prognostic and predictive cancer tests, has been granted de novo ...

ArteraAI Prostate is now an FDA-regulated software (as a medical device) to estimate long-term outcomes and predict the benefit of hormone therapy for individual patients with localized prostate ...

‘While the final version of Fixed feels fully unleashed, the uber-raunchy and ultra-horny ride may not appeal to everyone’s comedic tastes,’ Collider ’s review read, while critic Alan French wrote: ...